首頁 > 市場調查報告書 > 醫療設備

生技設備基因治療學和RNAi

市場調查報告書

商品編碼

1532593

無標籤陣列系統市場 - 按技術、應用、最終用途 - 全球預測

Label-free Array Systems Market - By Technology, Application, End-use - Global Forecast

出版日期: 2024年05月27日 | 出版商:

Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在即時照護 (POC) 診斷熱潮的推動下，全球無標籤陣列系統市場從 2024 年到 2032 年的複合年成長率將超過 7.2%。隨著醫療保健專業人員尋求無需複雜的樣品製備或標記即可提供即時分析的解決方案，對快速、準確和方便用戶使用的診斷工具的需求不斷增加。對現場診斷的需求推動了這一趨勢，現場診斷可以提供即時結果並促進及時決策。

無標籤陣列系統提供增強的診斷功能，支援更廣泛地採用即時偵測。舉個例子，2024年1月，HORIBA Medical推出了HELO 2.0高通量自動化血液學平台，現已獲得CE-IVDR批准，正在等待美國FDA批准。此新系統為大中型實驗室提供靈活的模組化配置，整合先進技術以提高效率和更環保的操作。

無標記陣列系統市場根據技術、應用、最終用途和地區進行細分。

由於對高解析度分子交互作用和即時分析能力的需求不斷增加，生物層干涉測量領域將在 2024 年至 2032 年間呈現出值得注意的複合年成長率。隨著生命科學研發的進步，人們越來越重視取得精確的、無標記的資料，以便更了解生物分子過程。這種轉變是由於對複雜生物測定中更準確和可重複結果的渴望所驅動的，從而導致更多地採用無需額外標記步驟即可提供直接和詳細測量的技術。

到 2032 年，由於對蛋白質動力學了解的需求不斷成長，蛋白質界面分析領域將佔據相當大的無標記陣列系統市場佔有率。研究人員和製藥公司致力於闡明複雜的蛋白質行為和相互作用，以推進藥物發現和開發。無標記技術提供了一種非侵入性、即時的方法來研究這些相互作用，在不受額外標記試劑干擾的情況下提供有價值的見解。這種以高精度和解析度直接分析蛋白質界面的能力正在推動無標記系統的採用。

到 2032 年，由於對生命科學研究的投資和對技術創新的高度重視，北美無標籤陣列系統市場將呈現出令人印象深刻的複合年成長率。研究機構和生技公司正在引領分子生物學的進步，需要先進的分析工具來實現高效率的資料收集。對個人化醫療和基因組學研究的日益重視，增強了對提供即時結果的無標籤技術的需求。政府資助和協作研究環境支持北美地區不斷成長的產品採用，有利於市場成長。

產業生態系統分析
產業影響力
- 成長動力
  - 增加藥物發現和開發活動
  - 生物技術與生命科學研究的進步
  - 慢性病和傳染病病例不斷增加
- 產業陷阱與挑戰
  - 初期投資成本高
  - 複雜性和技術專長要求
成長潛力分析
技術景觀
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按技術分類，2021 - 2032 年

主要趨勢
表面等離子共振
生物層干涉測量
細胞介電譜
微懸臂梁
掃描開爾文奈米探針
焓陣
原子力顯微鏡
其他技術

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
藥物發現
蛋白質界面分析
抗體表徵和開發
蛋白質複合物和級聯分析
疾病生物標記檢測
其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
製藥和生物技術公司
學術及研究機構
合約研究組織
醫院和診所
其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Agilent Technologies, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Corning Incorporated
Danaher Corporation
F. Hoffmann-La Roche AG
Illumina, Inc.
Merck KGaA
Meso Scale Diagnostics (MSD)
Nanion Technologies
Pall Corporation
PerkinElmer, Inc.
Sartorius AG
Siemens Healthineers AG
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 9649

Global Label-free Array Systems Market will register over 7.2% CAGR from 2024 to 2032, driven by the upsurge of point-of-care (POC) diagnostics. The demand for rapid, accurate, and user-friendly diagnostic tools is increasing as healthcare professionals seek solutions that offer real-time analysis without complex sample preparation or labeling. This trend is fueled by the need for on-the-spot diagnostics that provide immediate results and facilitate timely decision-making.

Label-free array systems offer enhanced diagnostic capabilities, supporting the broader adoption of point-of-care testing. Quoting an instance, in January 2024, HORIBA Medical launched the HELO 2.0 high-throughput automated hematology platform, now CE-IVDR approved and pending US FDA clearance. This new system offers flexible, modular configurations for mid to large-scale labs, integrating advanced technologies for improved efficiency and eco-friendlier operation.

The label-free array systems market is segmented based on technology, application, end-use, and region.

The bio-layer interferometry segment will evince a noteworthy CAGR between 2024 and 2032, due to the increasing need for high-resolution molecular interactions and real-time analytical capabilities. As R&D in life sciences advances, there is a growing emphasis on obtaining precise, label-free data to better understand biomolecular processes. The shift is driven by the desire for more accurate and reproducible results in complex biological assays, leading to higher adoption of technologies that offer direct and detailed measurement without the need for additional labeling steps.

By 2032, the protein interface analysis segment will grab a sizeable label-free array systems market share, attributed to the growing need for an understanding of protein dynamics. Researchers and pharmaceutical companies are focused on elucidating complex protein behaviors and interactions to advance drug discovery and development. Label-free technologies offer a non-invasive, real-time approach to studying these interactions, providing valuable insights without the interference of additional labeling agents. This ability to directly analyze protein interfaces with high accuracy and resolution is thriving the adoption of label-free systems.

Through 2032, North America label-free array systems market will show an impressive CAGR, due to investments in life sciences research and a strong focus on technological innovation. The research institutions and biotechnology companies are leading advancements in molecular biology, requiring advanced analytical tools for efficient data acquisition. The increasing emphasis on personalized medicine and genomics research is strengthening the need for label-free technologies that deliver real-time results. Government funding and a collaborative research environment support the growing product adoption across North America, favoring market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing drug discovery and development activities
  - 3.2.1.2 Advancements in biotechnology and life sciences research
  - 3.2.1.3 Rising cases of chronic and infectious diseases
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High initial investment cost
  - 3.2.2.2 Complexity and technical expertise requirements
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Surface plasmon resonance
5.3 Bio-layer interferometry
5.4 Cellular dielectric spectroscopy
5.5 Microcantilever
5.6 Scanning kelvin nanoprobe
5.7 Enthalpy array
5.8 Atomic force microscopy
5.9 Other technologies

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Drug discovery
6.3 Protein interface analysis
6.4 Antibody characterization and development
6.5 Protein complex and cascade analysis
6.6 Detection of disease biomarkers
6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Pharmaceutical & biotechnology companies
7.3 Academic & research institutes
7.4 Contract research organizations
7.5 Hospitals and clinics
7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa